Anticoagulant News and Research

RSS
Study reveals positive impact of Soliris on long-term outcomes in PNH patients

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

Sanofi's semuloparin Phase III study data against venous thromboembolism presented at ASCO 2011

Sanofi's semuloparin Phase III study data against venous thromboembolism presented at ASCO 2011

Alexion's sBLA for Soliris receives FDA Priority Review designation to treat aHUS

Alexion's sBLA for Soliris receives FDA Priority Review designation to treat aHUS

PolyMedix presents new pre-clinical data on antimicrobial compounds at two scientific meetings

PolyMedix presents new pre-clinical data on antimicrobial compounds at two scientific meetings

Patients with chronic heart failure can benefit from telemonitoring

Patients with chronic heart failure can benefit from telemonitoring

PolyMedix's PMX-30063 compound mitigates ulcerative mucositis in pre-clinical studies

PolyMedix's PMX-30063 compound mitigates ulcerative mucositis in pre-clinical studies

UW C4C, Pharmigene execute licensing agreement for warfarin personalized medicine technology

UW C4C, Pharmigene execute licensing agreement for warfarin personalized medicine technology

Thrombolytic therapy linked to poor survival in pulmonary embolism patients with normal blood pressure

Thrombolytic therapy linked to poor survival in pulmonary embolism patients with normal blood pressure

New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

PolyMedix Phase 1B/2 clinical study data presented at ATVB meeting

PolyMedix Phase 1B/2 clinical study data presented at ATVB meeting

Desirudin more effective for VTE prevention in patients with renal impairment

Desirudin more effective for VTE prevention in patients with renal impairment

BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

PolyMedix defensin-mimetic antibiotic compounds show antimicrobial efficacy against anthrax

PolyMedix defensin-mimetic antibiotic compounds show antimicrobial efficacy against anthrax

Daiichi Sankyo's LIXIANA receives Japanese marketing approval

Daiichi Sankyo's LIXIANA receives Japanese marketing approval

Boehringer Ingelheim's dabigatran etexilate receives positive opinion from EMA committee

Boehringer Ingelheim's dabigatran etexilate receives positive opinion from EMA committee

Alexion submits Soliris marketing applications to FDA, EMA for aHUS treatment

Alexion submits Soliris marketing applications to FDA, EMA for aHUS treatment

Supplements are less well regulated than drugs and may have side effects, drug interactions and toxicities

Supplements are less well regulated than drugs and may have side effects, drug interactions and toxicities

J&JPRD announces rivaroxaban Phase 3 trial results against venous thromboembolism

J&JPRD announces rivaroxaban Phase 3 trial results against venous thromboembolism

RE-LY trial results suggest Pradaxa capsule reduces risk of stroke in AF patients

RE-LY trial results suggest Pradaxa capsule reduces risk of stroke in AF patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.